PISCATAWAY, N.J., July 9, 2025 /PRNewswire/ -- GenScript Biotech Corporation (HK.1548), a leading global provider of life science research and manufacturing services, today announced that it has been awarded a Silver Medal by EcoVadis, a globally recognized business sustainability assessment platform. This recognition underscores its significant progress in the areas of environment, labor and human rights, ethics, and sustainable procurement. This silver medal places GenScript in the top 15% of all companies assessed by EcoVadis worldwide.
In the latest reassessment, GenScript outperforms 85% of companies globally and stands at the top 10% in the sector of manufacture of basic pharmaceutical products and pharmaceutical preparations. EcoVadis is a recognized business sustainability ratings organization covering over 220 industry categories across over 180 countries. Its methodology is based on international standards such as the United Nations Global Compact (UNGC), the Global Reporting Initiative (GRI), and ISO 26000, making it the "gold standard" in assessing corporate sustainability performance. The Silver Medal status is a strong validation of GenScript's continuous improvement in its sustainability management system and further reinforces its roles as a trusted partner for global partners.
"Securing the EcoVadis silver medal marks a significant breakthrough in GenScript's sustainability journey. This not only demonstrates ongoing commitment to environmental stewardship, social responsibility, and ethical practices, but highlights our progress in fostering a sustainable supply chain. Over the years, we have integrated sustainability into the core of our operations, driving operational efficiency and enabling us to support our global clients in meeting their sustainability goals. We are dedicated to working closely with our suppliers and partners to create a responsible and sustainable supply chain that benefits all stakeholders," said Sherry Shao, Rotating CEO of GenScript Biotech.
GenScript has garnered wide recognition from global sustainability organizations and ratings. As a member of the United Nations Global Compact (UNGC), the company upholds its ten principles covering human rights, labor, the environment, and anti-corruption. GenScript is also a supplier partner of the Pharmaceutical Supply Chain Initiative (PSCI), promoting sustainability in the pharmaceutical supply chain. The company has achieved an "A" rating from MSCI ESG Ratings and"Low Risk" rating from Morningstar Sustainalytics, and has been included in the FTSE4Good Index Series, underscoring its strong and balanced sustainability capabilities. GenScript's carbon reduction targets have also been approved by the Science Based Targets initiative (SBTi), demonstrating the company's firm commitment to addressing climate change.
Looking ahead, GenScript remains dedicated to its mission of "Making People and Nature Healthier through Biotechnology," and will continue integrating sustainability into its global business strategy. Through technological innovation and international collaboration, the company aims to lead the life sciences industry toward a greener and more responsible future, contributing meaningfully to global health and sustainable development.
About GenScript Biotech Corporation
Founded in 2002 in New Jersey, GenScript Biotech Corporation accelerates innovation in biotech and healthcare by providing researchers and companies with the building blocks needed to develop groundbreaking treatments and products. Guided by its mission to Make People and Nature Healthier Through Biotechnology, and its role as a trusted global leader, GenScript has a team of over 5,500 employees and has served more than 200,000 customers acrossover100 countries and regions.
Learn more here: https://www.genscript.com
